XML 75 R33.htm IDEA: XBRL DOCUMENT v3.22.1

Stockholders' Equity (Deficit) (Tables)

12 Months Ended

Dec. 31, 2021

Federal Home Loan Banks [Abstract]

Summary of Preferred Stock Allocated to Investors

The Purchase Agreement provides for the Company to issue and sell to the Investor shares of the Company’s preferred stock in the amounts set forth in the following table (numbers have been adjusted for the February 2016 reverse stock split):

Convertible Preferred Stock		Shares				Price Per Share				Total Investment
Series AA-1			8,427,004			$	12.00			$	101,124,048
Series AA-2			7,223,145			$	6.00				43,338,870
			15,650,149							$	144,462,918

Summary of Stock Option Activity

Additional information with respect to both plans stock option activity is as follows:

		Number of Shares				Weighted Average Exercise Price
Outstanding at December 31, 2018			238,651			$	15.95
Granted			—			$	—
Exercised			—			$	—
Cancelled			—			$	—
Outstanding at December 31, 2019			238,651			$	15.95
Granted			—			$	—
Exercised			—			$	—
Cancelled			—			$	—
Outstanding at December 31, 2020			238,651			$	15.95
Granted			—			$	—
Exercised			—			$	—
Cancelled			—			$	—
Outstanding at December 31, 2021			238,651			$	15.95
Options exercisable at December 31, 2019			238,651			$	15.95
Options exercisable at December 31, 2020			238,651			$	15.95
Options exercisable at December 31, 2021			238,651			$	15.95

Stock Options Outstanding

The following table summarizes information about stock options outstanding at December 31, 2021:

Stock Options Outstanding
Range of Exercise Prices		Number of Shares Outstanding				Weighted Average Remaining Contractual Life in Years				Weighted Average Exercise Price
$26.40 - $26.40			75,158				2.00			$	26.40
$12.48 - $12.84			141,000				3.00			$	12.48
$2.02 - $3.59			22,493				4.65			$	2.74
			238,651				2.84			$	15.95

Estimated Fair Value of Restricted Stock Award

The estimated fair value of each restricted stock award is calculated using the share price at the date of the grant. A summary of the status of the restricted stock awards as of December 31, 2021 and changes during the year ended December 31, 2021 is presented as follows:

		Number of Shares				Weighted Average Grant Date Fair Value
Unvested at December 31, 2020			249,391			$	5.18
Granted			254,559			$	7.05
Vested			(227,241	)		$	5.62
Cancelled			—			$	—
Unvested at December 31, 2021			276,709			$	6.54

Summary of Common Stock Warrants Outstanding

The following table summarizes our common stock warrants outstanding at December 31, 2021:

Common Stock Warrants				Exercise Price				Termination Date
	196,135			$	5.76			07/08/2024
	700,000			$	7.16			11/02/2023
	551,378			$	3.99			**
	131,816			$	4.67			08/14/2023
	1,901,985			$	4.75			02/25/2024
	3,481,314

** A five-year term commences upon the earliest occurrence of either Trigger Date A or Trigger Date B. Trigger Date A is the date on which the Claimholder ceases the Subject Claim for any reason other than (i) a full and final arbitral award against the Claimholder or (ii) a full and final monetary settlement of the claim, see NOTE H – Note 9 – Litigation financing.

X

- Definition

Preferred Stock Activity [Table Text Block]

+ References

No definition available.

+ Details

Name:	omex_PreferredStockActivityTableTextBlock
Namespace Prefix:	omex_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_FederalHomeLoanBanksAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration